Patent · US Active

System and method for diagnosis and treatment

US9320747B1 · kind B1 · utility

29Cited by
2References
8Claims
0Family size

Assignee

Inventors

Key dates

Filing dateDec 29, 2015
Grant dateApr 26, 2016
Priority date
Expiry dateDec 29, 2035

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2800/7004
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

This invention relates to a low cost rapid response diagnostic system to determine cortisol levels in patients selected as potential candidates for GCR (glucocorticoid receptor) antagonist therapy utilizing a GCR antagonist, such as ORG 34517. The rapid, sensitive, and inexpensive test can be used to determine patients who have non-normal cortisol production or disordered circadian rhythms as a method for selecting subjects for GCR antagonist therapy for whom it is likely to have beneficial and/or therapeutic effects, and can also be used to monitor changes in cortisol levels in response to treatment.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.